SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Elizabeth O. Ofili, Dion H. Zappe, Das Purkayastha, Rita Samuel, James R. Sowers, Antihypertensive and Metabolic Effects of Angiotensin Receptor Blocker/Diuretic Combination Therapy in Obese, Hypertensive African American and White Patients, American Journal of Therapeutics, 2013, 20, 1, 2

    CrossRef

  2. 2
    Steven G. Chrysant, Blood Pressure Effects of High-Dose Amlodipine-Benazepril Combination in Black and White Hypertensive Patients Not Controlled on Monotherapy, Drugs in R&D, 2012, 12, 2, 57

    CrossRef

  3. 3
    Steven G. Chrysant, Blood Pressure Effects of High-Dose Amlodipine-Benazepril Combination in Black and White Hypertensive Patients Not Controlled on Monotherapy, Drugs in R&D, 2012, 12, 2, 57

    CrossRef

  4. You have free access to this content4
    Addison A. Taylor, Helmy Siragy, Shawna Nesbitt, Angiotensin Receptor Blockers: Pharmacology, Efficacy, and Safety, The Journal of Clinical Hypertension, 2011, 13, 9
  5. 5
    Mark J. Wrobel, James J. Figge, Joseph L. Izzo, Hypertension in diverse populations: a New York State Medicaid clinical guidance document, Journal of the American Society of Hypertension, 2011, 5, 4, 208

    CrossRef

  6. 6
    Steen Neldam, Robert M Guthrie, Telmisartan/hydrochlorothiazide single-pill combination in the treatment of hypertension in elderly patients, Aging Health, 2011, 7, 2, 249

    CrossRef

  7. 7
    Rigas Kalaitzidis, George Bakris, Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers, Diabetes, Obesity and Metabolism, 2009, 11, 8
  8. 8
    Jan Basile, New Therapeutic Options in Patients Prone to Hypertension: A Focus on Direct Renin Inhibition and Aldosterone Blockade, The American Journal of the Medical Sciences, 2009, 337, 6, 438

    CrossRef

  9. You have free access to this content9
    Domenic A. Sica, Direct Renin Inhibition— Commonly Asked Questions, The Journal of Clinical Hypertension, 2008, 10, 11
  10. 10
    Edward P. Havranek, From Black and White to Shades of Gray, Journal of the American College of Cardiology, 2008, 51, 19, 1872

    CrossRef

  11. 11
    Byung-Hee Oh, Jerry Mitchell, James R. Herron, Jenny Chung, Mahmudul Khan, Deborah L. Keefe, Aliskiren, an Oral Renin Inhibitor, Provides Dose-Dependent Efficacy and Sustained 24-Hour Blood Pressure Control in Patients With Hypertension, Journal of the American College of Cardiology, 2007, 49, 11, 1157

    CrossRef

  12. 12
    Zafar H Israili, Rafael Hern??ndez-Hern??ndez, Manuel Valasco, The Future of Antihypertensive Treatment, American Journal of Therapeutics, 2007, 14, 2, 121

    CrossRef

  13. 13
    Matthias Goebel, Markus Clemenz, Thomas Unger, Effective treatment of hypertension by AT1receptor antagonism: the past and future of telmisartan, Expert Review of Cardiovascular Therapy, 2006, 4, 5, 615

    CrossRef